In the realm of diabetes management, medications like Trulicity (Dulaglutide) and Victoza (Liraglutide) are frequently prescribed to help control blood sugar levels. Both belong to the class of GLP-1 receptor agonists, yet they exhibit distinct characteristics in terms of their mechanisms of action, usage, and potential benefits. This article aims to provide a comprehensive comparison between Trulicity and Victoza, shedding light on their similarities, differences, and how they work to benefit patients with type 2 diabetes.
Article by: Austin Rhoads
Austin is the Co-Founder of Alterra Health and has been a leader in the development of weight loss education programs for patients and medical practitioners since 2018.
1) What are Trulicity & Victoza?
Trulicity (Dulaglutide):
Trulicity is a once-weekly injectable medication used primarily to treat type 2 diabetes. Approved by the FDA in 2014, it belongs to the GLP-1 receptor agonist class of drugs. Trulicity mimics the action of GLP-1, a hormone that enhances insulin secretion, suppresses glucagon release, and slows gastric emptying. These actions collectively help regulate blood sugar levels and promote weight loss as a secondary benefit.
Victoza (Liraglutide):
Victoza, on the other hand, is another GLP-1 receptor agonist that was approved earlier than Trulicity, in 2010. It is also used for the treatment of type 2 diabetes and shares similar mechanisms of action with Trulicity. Like Trulicity, Victoza stimulates insulin secretion, inhibits glucagon release, and delays gastric emptying. It is administered once daily via subcutaneous injection.
2) Mechanisms of action: How do Trulicity (Dulaglutide) & Victoza (Liraglutide) work?
GLP-1 receptor agonists:
Both Trulicity and Victoza work by binding to and activating GLP-1 receptors found throughout the body, particularly in the pancreas, stomach, and brain. The activation of these receptors triggers several physiological responses that are beneficial for individuals with type 2 diabetes:
Insulin secretion: GLP-1 receptor agonists enhance insulin secretion from pancreatic beta cells in response to elevated blood glucose levels. This helps to lower blood sugar levels after meals.
Glucagon suppression: They suppress the release of glucagon, a hormone that raises blood sugar levels by stimulating the liver to release glucose. By inhibiting glucagon release, GLP-1 receptor agonists help prevent excess glucose production.
Gastric emptying: GLP-1 receptor agonists slow down the rate at which food empties from the stomach into the small intestine. This delay promotes feelings of fullness, reduces appetite, and helps control postprandial (after-meal) blood sugar levels.
Weight loss: Both Trulicity and Victoza have been associated with weight loss in patients with type 2 diabetes. This effect is believed to result from appetite suppression, delayed gastric emptying, and possibly other metabolic changes induced by prolonged GLP-1 receptor activation.
3) What are the differences between Trulicity & Victoza?
While Trulicity and Victoza share similar mechanisms and therapeutic goals, there are notable differences that may influence treatment decisions:
Dosage & administration:
Trulicity is administered once weekly, whereas Victoza is given once daily. This difference in dosing frequency may impact patient adherence and convenience.
Clinical evidence:
Both medications have demonstrated efficacy in improving glycemic control and promoting weight loss in clinical trials. However, individual responses to each medication may vary, and healthcare providers may consider factors such as patient preferences and side effect profiles when choosing between them.
Side effects:
Common side effects of both Trulicity and Victoza include nausea, vomiting, diarrhea, and headache. However, the frequency and severity of these side effects can differ between the two medications.
4) A conclusion for individuals considering Trulicity, Victoza, & other GLP-1 medications for weight loss & diabetes management.
In conclusion, while Trulicity (Dulaglutide) and Victoza (Liraglutide) belong to the same class of medications and share similar mechanisms of action, they differ in terms of dosing frequency, administration, and possibly side effect profiles. Both medications are valuable options for managing type 2 diabetes and promoting weight loss, but the choice between them should be guided by individual patient needs, preferences, and healthcare provider recommendations. Always consult with a healthcare professional to determine the most appropriate treatment plan for managing your diabetes effectively.
Are you having trouble overcoming a weight loss plateau on your GLP-1 medical weight loss journey? Click here to download our free guide with nutrition, exercise, and mindset tips to help you continue making progress!
You can also find tons of expert recommendations in our free Facebook Support Group for GLP-1 patients.
Alterra Health and its parent company Puente Holdings, LLC provide education, coaching, guides, support, and programs for patients. Individual results may vary. This article should not be construed as medical advice. For all clinical questions, please consult your medical provider.